Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy-Reference-Cited by-同舟云学术

Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy

Published:2024-01 Issue:1 Volume:8 Page:10-17
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Szigiato Andrei^ORCID,Mohan Nitesh^ORCID,Talcott Katherine E.,Mammo Danny A.^ORCID,Babiuch Amy S.,Kaiser Peter K.^ORCID,Ehlers Justis P.^ORCID,Rachitskaya Aleksandra,Yuan Alex^ORCID,Srivastava Sunil K.,Sharma Sumit^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Ophthalmology

Reference23 articles.

1. Age-related macular degeneration;Mitchell;Lancet,2018

2. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

3. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration;Heier;Ophthalmology,2012

4. HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration;Dugel;Ophthalmology,2020

5. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results;Martin;Ophthalmology,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration;International Ophthalmology;2024-09-05

2. Targeting the Tie-2 Receptor with Faricimab in Central Serous Chorioretinopathy: A Case Series Motivated by a Genetic Finding;American Journal of Ophthalmology;2024-09

3. Short-term Outcomes of Faricimab for Neovascular Age-related Macular Degeneration with Limited Response to Ranibizumab or Aflibercept;Journal of the Korean Ophthalmological Society;2024-08-15

4. Long-acting delivery and therapies for neovascular age-related macular degeneration;Expert Opinion on Biological Therapy;2024-07-22

5. Short-Term Comparison of Switching to Brolucizumab or Faricimab from Aflibercept in Neovascular AMD Patients;Medicina;2024-07-19